ADC Therapeutics SA

Ownership Transactions Reported by 15 Insiders

Symbol
ADCT on NYSE
Location
Biopole, Route De La Corniche 3 B, Epalinges, Switzerland

Insiders trading volume in the past year

ADC Therapeutics SA executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Redmile Group, LLC 10%+ Owner $220M +$71.5M +48% Dec 11, 2024
Hans Peter Wild 10%+ Owner $43.9M Jan 2, 2024
Ameet Mallik Chief Executive Officer, Director $2.91M -$133K -4.38% Dec 6, 2024
Thomas Pfisterer Director $1.92M -$4.15K -0.22% Jun 17, 2024
Jose Carmona Chief Financial Officer $945K Dec 6, 2024
Mohamed Zaki Chief Medical Officer $729K Dec 6, 2024
Peter Graham Chief Legal Officer $590K Dec 6, 2024
Peter Hug Director $528K -$3.45K -0.65% Jun 17, 2024
Viviane Monges Director $308K -$4.15K -1.33% Jun 17, 2024
Victor Sandor Director $234K -$20.2K -7.96% Jun 17, 2024
Ron Squarer Director $233K -$20.2K -7.98% Jun 17, 2024
Jean Pierre Bizzari Director $230K -$20.2K -8.09% Jun 17, 2024
Robert Azelby Director $153K -$20.2K -11.7% Jun 17, 2024
Lisa Kallebo Chief Accounting Officer $113K Dec 6, 2024
Tyrell Rivers Director Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for ADC Therapeutics SA

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.